Bio-Caps India Limited - pharma in Kolkata, West Bengal, India. FY 2026 financials & compliance.
CIN U24239WB2003PLC095890 Incorporated 06 March 2003 ROC Kolkata HQ Kolkata, West Bengal, India
Active Public Limited Company pharma
Data last updated
Revenue · FY 2025
₹22.36 Cr
▲ 4% YoY
Net loss · FY 2025
₹7.72 Lakh
Net margin -0.3%
EBITDA · FY 2025
₹2.61 Cr
EBITDA margin 11.7%
Authorised capital
₹3.53 Cr
Registered with MCA
Paid-up capital
₹3.4 Cr
Issued & subscribed
Open charges
₹7.56 Cr
Satisfied ₹25.88 Cr
Company age
23 yrs
Est. 2003
Employees · EPFO
95
Provident fund records

About Bio-Caps India Limited

Data last updated:

Bio-Caps India Limited is a public limited company based in Kolkata, West Bengal, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 06 March 2003 and has been in existence for over 23 years.

The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24239WB2003PLC095890. Its GSTIN is 19AACCB1693H1ZL (West Bengal).

The company has an authorised share capital of ₹3.53 Cr and a paid-up capital of ₹3.4 Cr. It is led by directors including Ajit Agrawal and Tarasankar Bhattacharjee.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Dankuni Expressway Post – Dankuni Cole Complex, Kolkata, West Bengal, India – 712310.

As per the financials filed for FY 2025, the company reported a revenue of ₹22.36 Cr, a growth of 4% compared to the previous year. For the same year it recorded a net loss of ₹7.72 Lakh (net margin -0.3%) and EBITDA of ₹2.61 Cr (EBITDA margin 11.7%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 13% over five years.

The company has about 95 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Bio-Caps. As per MCA filings, the company has open charges of ₹7.56 Cr and satisfied charges of ₹25.88 Cr on record. Court records list 12 cases involving the company, including 11 filed by the company and 1 filed against it; 4 cases are pending.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website biocaps.in.

Company details

CIN U24239WB2003PLC095890
Registration Number 095890
Incorporation Date 06 March 2003
ROC Kolkata
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant

CIN history

Bio-Caps India has one previous CIN (Corporate Identification Number): U24239WB2003PTC095890. The current CIN is U24239WB2003PLC095890, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24239WB2003PLC095890Current
U24239WB2003PTC095890Previous

Contact details

Bio-Caps India Limited's registered office is in Kolkata, West Bengal. Its website is biocaps.in. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
  • Social Media
  • Registered Address
    Dankuni Expressway Post – Dankuni Cole Complex, Kolkata, West Bengal, India – 712310
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Bio-Caps India Limited, buy the company report.

Comprehensive company report
Bio-Caps India Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Bio-Caps India operates one associated brand: Bio-Caps. Each brand links to its own profile.

BrandDescriptionWebsite
Produces empty hard gelatin capsules for global pharmaceutical clients.biocaps.in

Business activity

The main business activity of Bio-Caps India is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Bio-Caps India Limited, buy the company report.

Financials of Bio-Caps India Limited

FY 2025 filings available

Bio-Caps India Limited reported revenue of ₹22.36 Cr (up 4% YoY) for FY 2025.

Revenue · FY 2025
₹22.36 Cr ▲ 4%
Net loss · FY 2025
₹7.72 Lakh margin -0.3%
EBITDA · FY 2025
₹2.61 Cr margin 11.7%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 4%
3 years · compounded
▼ 3%
5 years · compounded
▲ 13%
EBITDA CAGR growth
1 year
▲ 1%
3 years · compounded
▼ 6%
5 years · compounded
▲ 14%

Revenue has grown at a compounded annual rate (CAGR) of 13% over five years, including 4% growth in the latest year. EBITDA rose 1% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹2.61 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹7.72 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin11.7%
Net Profit Margin-0.3%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Bio-Caps India Limited, buy the company report.

Board of directors of Bio-Caps India Limited

Bio-Caps India has 3 current directors and 10 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Ajit AgrawalDirector06 Mar 200323 Years 8 MonthsCurrent
Amitava DeyAdditional Director30 Jan 20260 Years 9 MonthsCurrent
Tarasankar BhattacharjeeDirector25 Aug 20251 Years 2 MonthsCurrent

Peer comparison

Bio-Caps India Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Cito Chem Industries Pvt.Ltd.₹22.46 Cr (FY 2025)-18.0%Indore, Madhya Pradesh, India
Bhargava's Hi-Tech Surgimed Company Private Limited₹22.39 Cr (FY 2025)29.0%Jaipur, Rajasthan, India
Bio-Caps India Limitedthis company₹22.36 Cr (FY 2025)-₹7.72 Lakh-0.3%4.0%95Kolkata, West Bengal, India
Lifecare Formulations Private Limited₹22.33 Cr (FY 2025)23.0%Puducherry, India
Sapient Laboratories Private Limited₹22.2 Cr (FY 2024)5.0%New Delhi, Delhi, India

To see the full peer comparison of Bio-Caps India Limited, buy the company report.

Auditor

Bio-Caps India Limited is audited by Vivek Jaiswal & Co. for the financial year 2023.

Auditor firmFinancial yearFirm registration number
Vivek Jaiswal & Co.FY 2023AADFV4593J

Shareholding

The shareholding of Bio-Caps India Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2021FY 2020FY 2019FY 2018FY 2017
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Bio-Caps India Limited, buy the company report.

Charges & borrowings

Open charges
₹7.56 Cr
Satisfied charges
₹25.88 Cr
Breakdown by lending institutions
Others₹6.86 Cr
Hdfc Bank Limited₹0.70 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
18 Jan 2024100869605Others₹6 CrOpen
30 Nov 2023100872442Others₹86.16 LakhOpen
07 Mar 2022100570377Hdfc Bank Limited₹20 LakhOpen
11 Dec 2020100408123Hdfc Bank Limited₹49.9 LakhOpen
31 Dec 2022100673969Others₹4.5 CrSatisfied

To see the full charge records of Bio-Caps India Limited, buy the company report.

Total charge records: 7 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Bio-Caps India Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Bio-Caps India Limited has a workforce of 95 employees on its EPFO records as of Apr 04, 2024, across 1 active EPFO establishment.

Employee count
95
Active EPFO establishments
1
Employee growth
9.2%

GST

Bio-Caps India has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
19AACCB1693H1ZLWest BengalActive01 Jul 2017

To see the full GST registrations and return filing status of Bio-Caps India Limited, buy the company report.

Recent activity

Bio-Caps India Limited has 22 board changes on record since 2003: 12 appointments and 10 cessations. The latest: Amitava Dey was appointed as Additional Director on 30 Jan 2026.

Appointed
Amitava Dey was appointed as Additional Director.
Ceased
Anurag Sonthalia ceased to be Director.
Ceased
Rajendra Kumar Sonthalia ceased to be Director.
AGM
Bio-Caps India Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Ceased
Ashok Kumar Jain ceased to be Additional Director.
Appointed
Tarasankar Bhattacharjee was appointed as Director.
Filing
Bio-Caps India Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kolkata Ii.
Charges
A charge registered on 31 Dec 2022 via Charge ID 100673969 with Others was fully satisfied on 22 Feb 2024.
Charges
A charge with Others amounted to Rs. 6.00 Cr with Charge ID 100869605 was registered on 18 Jan 2024.
Charges
A charge with Others amounted to Rs. 0.86 Cr with Charge ID 100872442 was registered on 30 Nov 2023.
Charges
A charge with Others amounted to Rs. 4.50 Cr with Charge ID 100673969 was registered on 31 Dec 2022.
Ceased
Manju Sonthalia ceased to be Director.

25 earlier events are in the company report.

Frequently asked questions

Bio-Caps India is an active public limited company based in Kolkata, West Bengal, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 06 March 2003 (23+ years old) and is registered under CIN U24239WB2003PLC095890.

Bio-Caps India has 3 current directors:

The latest financial statements of Bio-Caps India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Bio-Caps India is 19AACCB1693H1ZL, registered in West Bengal.

The CIN (Corporate Identification Number) of Bio-Caps India is U24239WB2003PLC095890. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Bio-Caps India has 12 court cases on record: 11 filed by the company and 1 filed against it. 4 are pending. Most are in the district courts.

Bio-Caps India was incorporated on 06 March 2003, making it 23+ years old. It is registered with the Registrar of Companies, Kolkata.

The peers of Bio-Caps India by revenue are Cito Chem Industries Pvt.Ltd, Bhargava's Hi-Tech Surgimed Company Private Limited, Lifecare Formulations Private Limited, Sapient Laboratories Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Amitava Dey was appointed as Additional Director on 30 Jan 2026. Anurag Sonthalia ceased to be Director on 06 Nov 2025. Rajendra Kumar Sonthalia ceased to be Director on 06 Nov 2025. Bio-Caps India has 22 board changes on record in total.

Bio-Caps India can be reached through the website biocaps.in. Its registered office is in Kolkata, West Bengal, India.

The registered office of Bio-Caps India is at Dankuni Expressway Post – Dankuni Cole Complex, Kolkata, West Bengal, India – 712310.